These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17296405)

  • 21. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Roehrborn CG; Kaminetsky JC; Auerbach SM; Wachs B; Young JM; Esler A; Sides GD; Denes BS
    J Urol; 2007 Apr; 177(4):1401-7. PubMed ID: 17382741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotoresection versus transurethral resection of the prostate: short-term evaluation of a prospective randomized study.
    Soliman SA; Wadie BS; Ibrahim el-HE; Shehab El-Dein AB
    J Urol; 2007 Mar; 177(3):1036-9. PubMed ID: 17296407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
    Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
    Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Office based transurethral needle ablation of the prostate with analgesia and local anesthesia.
    Leocádio DE; Frenkl TL; Stein BS
    J Urol; 2007 Nov; 178(5):2052-4; discussion 2054. PubMed ID: 17869294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study.
    Flanigan RC; Reda DJ; Wasson JH; Anderson RJ; Abdellatif M; Bruskewitz RC
    J Urol; 1998 Jul; 160(1):12-6; discussion 16-7. PubMed ID: 9628595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement.
    Gittelman M; Ramsdell J; Young J; McNicholas T
    J Urol; 2006 Sep; 176(3):1045-50; discussion 1050. PubMed ID: 16890688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar transurethral resection in saline--an alternative surgical treatment for bladder outlet obstruction?
    Michielsen DP; Debacker T; De Boe V; Van Lersberghe C; Kaufman L; Braeckman JG; Amy JJ; Keuppens FI
    J Urol; 2007 Nov; 178(5):2035-9; discussion 2039. PubMed ID: 17869297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
    Schulman CC; Zlotta AR
    Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
    Zhao Z; Wang G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of transurethral needle ablation on symptoms of chronic pelvic pain syndrome--a pilot study.
    Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2001 Apr; 35(2):127-31. PubMed ID: 11411655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
    Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
    BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transurethral resection in women with lower urinary tract symptoms.
    Qiu Y; DU C; Shen X
    Int J Urol; 2004 Dec; 11(12):1097-103. PubMed ID: 15663682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term efficacy of transurethral electrovaporization of the prostate for symptomatic benign prostatic hyperplasia].
    Shao Q; Lu W; Zhang Y
    Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):440-2. PubMed ID: 11829885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC
    Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.